The study aimed to determine of some Optimum conditions for bioremediation and removing of seven mineral elements included hexavalent chromium, nickel, cobalt, cadmium, lead, iron and copper as either alone or in group by living and heat treated cells of baker’s yeast Saccharomyces cerevisiae. The dried baker's yeast from Aldnaamaya China Company was used in this study. Biochemical tests was used to ensure yeast belonging to S. cerevisiae and then used to remove the mentioned mineral elementes under different conditions which included incubation period, pH, and temperature. It was found that the best of these conditions was 60 minutes for duration of incubation, 6 for pH, 25 ᵒC for temperature. During the study the behavior of living

Magnesium oxide nanoparticles were synthesized via a co-precipitation procedure. Comprehensive characterization included infrared fluorescence, X-ray scattering spectroscopy, scanning electron microscopy, as well as X-ray diffraction and atomic force microscopy. Surface properties were analyzed using Langmuir, Brunauer -Emmett-Teller, Barrett–Joyner–Halenda, t-plot techniques, and the N2 adsorption-desorption isotherms methods to determine surface area and pore structure. Results confirmed the nanoparticles possess high purity. The size of the synthesized particles ranged from 30-40 nm, which was determined by scanning electron microscopy. The surface area of the prepared particles is 31,227 m2 g-1, and it was found that the por

Incident laser power and concentration effects on fluorescence emission from DCM dye in PMMA polymer have been investigated. Different concentrations of the dye were used. It was found that the fluorescence intensity increased with increasing of the concentration of the dye, with a red shift. In addition, it was found that the fluorescence intensity increased with the increase of the incident laser power I0.

It is well known that monotherapy does not provide therapeutic response in all hypertensive. Somepatients show an excellent response, while in others there is a poor response. Combinationantihypertensive therapy is administered when blood pressure is inadequately controlled bymonotherapy to achieve a balanced and additive antihypertensive effect with minimum adverse effects.Both angiotensin converting enzyme (ACE) inhibitors and dihydropyridine type of calcium antagonistsare well established and widely used in monotherapy. An understanding of differences in themechanism of action of these agents allows a logical approach for the use of these agents as acombination therapy. This study was designed to evaluate the possible beneficial